# Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Abbreviated New Drug Applications and 505(b)(2) Applications
**AGENCY:**
Food and Drug Administration, HHS.
**ACTION:**
Notice.
**SUMMARY:**
The Food and Drug Administration (FDA) is announcing that a collection of information entitled “Abbreviated New Drug Applications and 505(b)(2) Applications” has been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995.
**FOR FURTHER INFORMATION CONTACT:**
FDA PRA Staff, Office of Operations, Food and Drug Administration, Three White Flint North, 10A-12M, 11601 Landsdown St., North Bethesda, MD 20852, *[email protected].*
**SUPPLEMENTARY INFORMATION:**
On October 6, 2016, the Agency submitted a proposed collection of information entitled “Abbreviated New Drug Applications and 505(b)(2) Applications” to OMB for review and clearance under 44 U.S.C. 3507. An Agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number. OMB has now approved the information collection and has assigned OMB control number 0910-0786. The approval expires on November 30, 2019. A copy of the supporting statement for this information collection is available on the Internet at *http://www.reginfo.gov/public/do/PRAMain.*
Dated: November 22, 2016.
Leslie Kux,
Associate Commissioner for Policy.